Trials / Unknown
UnknownNCT04734236
Development of Molecular Diagnostic Platform for Tuberculosis
Development of a Rapid and Accurate Diagnostic Assay for Tuberculosis by Using New Sample Preparation and Detection Technique
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates new technique for diagnosis of tuberculosis. Among patients who are suspected with tuberculosis, participants will be tested conventional method including Xpert TB/RIF assay, and new diagnostic technique using homobifunctionalImidoesters compounds.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | New technique vs Xpert | New technique vs Xpert |
Timeline
- Start date
- 2021-01-28
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2021-02-02
- Last updated
- 2021-02-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04734236. Inclusion in this directory is not an endorsement.